🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05798013
Starting soon Not applicable

Effectiveness of Digital Health Management on Patients With Head and Neck Vascular Stenosis

NCT05798013 · tracked via the Priya Life Science China tracker
Sponsor
Yi Yang
Phase
Not applicable
Started
2025-10
Last updated
2024-10-02

Condition(s) studied

Head and Neck Vascular Stenosis

Investigational drug(s) / intervention(s)

Digital health management

Digital health management: The digital health management platform mainly includes reminding patients to take medication on time, monitoring and managing risk factors, reminding patients of regular review and regular follow-up, pushing personalized science according to patients' risk factors, etc., as well as following up and supervising patients' health management, and conducting regular formal medical science conferences.

Study summary

The purpose of this study is to evaluate the effectiveness of digital health management for intervention on Chinese population with head and neck vascular stenosis.

Eligibility

Sex
ALL
Min age
35 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Inclusion criteria of the clusters Hospitals with the qualification of "head and neck ultrasound center" in China. 2. Inclusion criteria for individuals * (1)Age ≥ 35 years old, with no restriction on gender. * (2)Patients with clinically diagnosed head and neck stenosis or occlusion, including mild, moderate or severe stenosis or occlusion of the carotid artery and mild, moderate or severe stenosis or occlusion of the intracranial artery. * (3)Ability to use a smartphone and have a mobile application installed on the handset. * (4)Subjects or their legal representatives agreed to the study and signed the project informed consent form. Exclusion Criteria: 1. Exclusion criteria for the clusters The included centers did not have the capacity to undertake the trial. 2. Exclusion criteria for individuals * (1)Combination of severe systemic diseases such as respiratory failure, renal failure, gastrointestinal bleeding, coagulation dysfunction, malignancy, etc. * (2)Patients with a life expectancy of less than 2 years or who are unable to complete the study for other reasons.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
First Hospital of Jilin University Changchun Jilin

More Yi Yang trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05798013 on ClinicalTrials.gov ↗ ← All trials in China